Research Studies

Protocol	Number	Status
Medication Treatment for Opioid-dependent Expecting Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations	CTN-0080	Development
Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT)	CTN-0079	Development
Knowledge of and Attitudes about Medication Assisted Treatment within American Indian Communities	CTN-0078	Active
Medical Cannabis Use among Primary Care Patients: Using Electronic Health Records to Study Large Populations	CTN-0077	Development
Clinical decision support for Opioid use disorders in Medical settings: Pilot Usability Testing in an EMR (COMPUTE)	CTN-0076	Active
Pharmacy Screening and Collaborative Opioid Use Disorder Care (Pharm-OUD-Care)	CTN-0075	Active
Primary Care Opioid Use Disorders Treatment Trial	CTN-0074	Active
Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network	CTN-0073	Active
Patient and System-Level Factors Associated with HEDIS AOD-IET Measure Performance across Health Systems	CTN-0072	Completed
Electronic Health Records Data Elements Research (EHR-DARE)	CTN-0071	Completed
Interpretation and Implementation of Title 42 CFR Part 2 for Confidentiality of Patient Drug and Alcohol Use Records: NIDA CTN Stakeholder Snapshot	CTN-0070	Completed
Opioid Use Disorder in the Emergency Department	CTN-0069	Active
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder	CTN-0068	Active
Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES); Scale-Up	CTN-0067	Development
Opioid Use Disorders in Primary Care Settings: Linking EHRs with PDMP and National Death Index Data Systems	CTN-0066	Completed
Evaluation of Drug Screening Implementation in Primary Care	CTN-0065	Completed
Linkage to Hepatitis C Virus Care among HIV/HCV Co-infected Substance Users	CTN-0064	Completed
Gender Differences in the Interrelationships between Sexual Abuse, Risky Sexual Behavior, and Anxiety/Depression in Treatment Efficacy and Drug Use over Time among Individuals with Substance Use Disorders	CTN-0063	Completed
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements into the Electronic Health Record in Large Primary Care Settings	CTN-0062	Active
Kaiser Virtual Data Warehouse - Prescription Opioid Users	CTN-0061	Completed
Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse Brief screen/assessment tool (TAPS Tool)	CTN-0059	Completed
Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC): An add-on project to “Duke University CMS Innovation Award Southeastern Diabetes Initiative”	CTN-0057	Completed
Testing and Linkage to HIV Care in China: a Cluster Randomized Trial	CTN-0056	Completed
Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES)	CTN-0055	Completed
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT)	CTN-0054	Completed
Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment (ACCENT)	CTN-0053	Completed
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)	CTN-0052	Completed
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)	CTN-0051	Completed
The START Follow-Up Study	CTN-0050	Completed
Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users	CTN-0049	Completed
Cocaine Use Reduction with Buprenorphine (CURB)	CTN-0048	Completed
Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED)	CTN-0047	Completed
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes	CTN-0046	Completed
Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders	CTN-0044	Completed
Stimulant Reduction Intervention using Dosed Exercise	CTN-0037	Completed
HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.	CTN-0032	Completed
An Evaluation of Neurocognitive Function, Oxidative Damage, and their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers	CTN-0031-A-1	Completed
Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement	CTN-0031	Completed
Prescription Opioid Addiction Treatment Study (POATS)	CTN-0030	Completed
A Pilot Study of Osmotic-Release Methylphenidate (OROS-MPH) in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder (ADHD)	CTN-0029	Completed
Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder in Adolescents with Substance Use Disorders	CTN-0028	Completed
Starting Treatment with Agonist Replacement Therapies (START) Study	CTN-0027	Completed
Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse	CTN-0021	Completed
Job-Seekers Training for Patients with Drug Dependence	CTN-0020	Completed
Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment	CTN-0019	Completed
Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment	CTN-0018	Completed
HIV and HCV Intervention in Drug Treatment Settings	CTN-0017	Completed
Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment	CTN-0016	Completed
Women's Treatment for Trauma and Substance Use Disorders	CTN-0015	Completed
Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abusers	CTN-0014	Completed
Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users	CTN-0013	Completed
Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs	CTN-0012	Completed
A Feasibility Study of a Telephone Enhancement Procedure (TELE) To Improve Participation in Continuing Care Activities	CTN-0011	Completed
Buprenorphine/Naloxone (Bup/Nx) Facilitated Rehabilitation for Heroin Addicted Adolescents/Young Adults	CTN-0010	Completed
Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs	CTN-0009	Completed
A Baseline for Investigating Diffusion of Innovation	CTN-0008	Completed
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics	CTN-0007	Completed
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics	CTN-0006	Completed
Motivational Interviewing (MI) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse	CTN-0005	Completed
MET (Motivational Enhancement Treatment) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse	CTN-0004	Completed
Suboxone® (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules	CTN-0003	Completed
Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Outpatient Opiate Detoxification	CTN-0002	Completed
Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Inpatient Opiate Detoxification	CTN-0001	Completed

Menu

CCTN

CTN Dissemination Initiative